These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 35447147

  • 1. Obscurin regulates ankyrin macromolecular complex formation.
    Subramaniam J, Yamankurt G, Cunha SR.
    J Mol Cell Cardiol; 2022 Jul; 168():44-57. PubMed ID: 35447147
    [Abstract] [Full Text] [Related]

  • 2. Identification and characterization of self-association domains on small ankyrin 1 isoforms.
    Subramaniam J, Yang P, McCarthy MJ, Cunha SR.
    J Mol Cell Cardiol; 2020 Feb; 139():225-237. PubMed ID: 32035138
    [Abstract] [Full Text] [Related]

  • 3. Obscurin and KCTD6 regulate cullin-dependent small ankyrin-1 (sAnk1.5) protein turnover.
    Lange S, Perera S, Teh P, Chen J.
    Mol Biol Cell; 2012 Jul; 23(13):2490-504. PubMed ID: 22573887
    [Abstract] [Full Text] [Related]

  • 4. Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.
    Bagnato P, Barone V, Giacomello E, Rossi D, Sorrentino V.
    J Cell Biol; 2003 Jan 20; 160(2):245-53. PubMed ID: 12527750
    [Abstract] [Full Text] [Related]

  • 5. Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.
    Cunha SR, Mohler PJ.
    J Biol Chem; 2008 Nov 14; 283(46):31968-80. PubMed ID: 18782775
    [Abstract] [Full Text] [Related]

  • 6. Electrostatic interactions mediate binding of obscurin to small ankyrin 1: biochemical and molecular modeling studies.
    Busby B, Oashi T, Willis CD, Ackermann MA, Kontrogianni-Konstantopoulos A, Mackerell AD, Bloch RJ.
    J Mol Biol; 2011 Apr 29; 408(2):321-34. PubMed ID: 21333652
    [Abstract] [Full Text] [Related]

  • 7. Molecular interactions with obscurin are involved in the localization of muscle-specific small ankyrin1 isoforms to subcompartments of the sarcoplasmic reticulum.
    Armani A, Galli S, Giacomello E, Bagnato P, Barone V, Rossi D, Sorrentino V.
    Exp Cell Res; 2006 Nov 01; 312(18):3546-58. PubMed ID: 16962094
    [Abstract] [Full Text] [Related]

  • 8. Obscurin is a ligand for small ankyrin 1 in skeletal muscle.
    Kontrogianni-Konstantopoulos A, Jones EM, Van Rossum DB, Bloch RJ.
    Mol Biol Cell; 2003 Mar 01; 14(3):1138-48. PubMed ID: 12631729
    [Abstract] [Full Text] [Related]

  • 9. Obscurin is required for ankyrinB-dependent dystrophin localization and sarcolemma integrity.
    Randazzo D, Giacomello E, Lorenzini S, Rossi D, Pierantozzi E, Blaauw B, Reggiani C, Lange S, Peter AK, Chen J, Sorrentino V.
    J Cell Biol; 2013 Feb 18; 200(4):523-36. PubMed ID: 23420875
    [Abstract] [Full Text] [Related]

  • 10. Mapping the binding site on small ankyrin 1 for obscurin.
    Borzok MA, Catino DH, Nicholson JD, Kontrogianni-Konstantopoulos A, Bloch RJ.
    J Biol Chem; 2007 Nov 02; 282(44):32384-96. PubMed ID: 17720975
    [Abstract] [Full Text] [Related]

  • 11. Hydrophobic residues in small ankyrin 1 participate in binding to obscurin.
    Willis CD, Oashi T, Busby B, Mackerell AD, Bloch RJ.
    Mol Membr Biol; 2012 Mar 02; 29(2):36-51. PubMed ID: 22416964
    [Abstract] [Full Text] [Related]

  • 12. Obscurin determines the architecture of the longitudinal sarcoplasmic reticulum.
    Lange S, Ouyang K, Meyer G, Cui L, Cheng H, Lieber RL, Chen J.
    J Cell Sci; 2009 Aug 01; 122(Pt 15):2640-50. PubMed ID: 19584095
    [Abstract] [Full Text] [Related]

  • 13. Novel interactions of ankyrins-G at the costameres: the muscle-specific Obscurin/Titin-Binding-related Domain (OTBD) binds plectin and filamin C.
    Maiweilidan Y, Klauza I, Kordeli E.
    Exp Cell Res; 2011 Apr 01; 317(6):724-36. PubMed ID: 21223964
    [Abstract] [Full Text] [Related]

  • 14. The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle.
    Ford-Speelman DL, Roche JA, Bowman AL, Bloch RJ.
    Mol Biol Cell; 2009 Sep 01; 20(17):3905-17. PubMed ID: 19605563
    [Abstract] [Full Text] [Related]

  • 15. Identification of Small Ankyrin 1 as a Novel Sarco(endo)plasmic Reticulum Ca2+-ATPase 1 (SERCA1) Regulatory Protein in Skeletal Muscle.
    Desmond PF, Muriel J, Markwardt ML, Rizzo MA, Bloch RJ.
    J Biol Chem; 2015 Nov 13; 290(46):27854-67. PubMed ID: 26405035
    [Abstract] [Full Text] [Related]

  • 16. Deletion of small ankyrin 1 (sAnk1) isoforms results in structural and functional alterations in aging skeletal muscle fibers.
    Giacomello E, Quarta M, Paolini C, Squecco R, Fusco P, Toniolo L, Blaauw B, Formoso L, Rossi D, Birkenmeier C, Peters LL, Francini F, Protasi F, Reggiani C, Sorrentino V.
    Am J Physiol Cell Physiol; 2015 Jan 15; 308(2):C123-38. PubMed ID: 25354526
    [Abstract] [Full Text] [Related]

  • 17. Characterization and comparison of two binding sites on obscurin for small ankyrin 1.
    Busby B, Willis CD, Ackermann MA, Kontrogianni-Konstantopoulos A, Bloch RJ.
    Biochemistry; 2010 Nov 23; 49(46):9948-56. PubMed ID: 20949908
    [Abstract] [Full Text] [Related]

  • 18. Localization of ank1.5 in the sarcoplasmic reticulum precedes that of SERCA and RyR: relationship with the organization of obscurin in developing sarcomeres.
    Giacomello E, Sorrentino V.
    Histochem Cell Biol; 2009 Mar 23; 131(3):371-82. PubMed ID: 19002483
    [Abstract] [Full Text] [Related]

  • 19. Identification and characterization of two ankyrin-B isoforms in mammalian heart.
    Wu HC, Yamankurt G, Luo J, Subramaniam J, Hashmi SS, Hu H, Cunha SR.
    Cardiovasc Res; 2015 Sep 01; 107(4):466-77. PubMed ID: 26109584
    [Abstract] [Full Text] [Related]

  • 20. When is an obscurin variant pathogenic? The impact of Arg4344Gln and Arg4444Trp variants on protein-protein interactions and protein stability.
    Fukuzawa A, Koch D, Grover S, Rees M, Gautel M.
    Hum Mol Genet; 2021 Jun 09; 30(12):1131-1141. PubMed ID: 33438037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.